22 assets in Bronchiectasis

Therapeutic assets addressing Bronchiectasis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ciprofloxacin Bronchiectasis	Centre Hospitalier Intercommunal Creteil	P4	BBB (76)
Azithromycin Bronchiectasis	Assiut University	P4	BBB (73)
Colistimethate Bronchiectasis	Centre Hospitalier Intercommunal Creteil	P3	BB (67)
Ceftolozane Bronchiectasis	Sunshine Coast Hospital and Health Service	P4	BB (65)
Tazobactam Bronchiectasis	Sunshine Coast Hospital and Health Service	P4	BB (65)
hsk31858 Bronchiectasis	Haisco Pharmaceutical Group Co., Ltd.	P3	B (62)
Itraconazole Bronchiectasis	Post Graduate Institute of Medical Education and Research, Chandigarh	P3	B (60)
Moxifloxacin Bronchiectasis	Assiut University	P3	B (60)
csl787 Bronchiectasis	CSL Behring	P2	B (58)
Ap-Pa02 Bronchiectasis	Armata Pharmaceuticals, Inc.	P2	B (57)
Arina-1 Bronchiectasis	Renovion, Inc.	P2	B (57)
bi 1291583 Bronchiectasis	Boehringer Ingelheim	P2	B (57)
Ensifentrine Bronchiectasis	Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA	P2	CCC (53)
sar445399 Bronchiectasis	Sanofi	P2	CCC (53)
Resp302 Bronchiectasis	Thirty Respiratory Limited	P1/2	CC (45)
Resp303 Bronchiectasis	Thirty Respiratory Limited	P1/2	CC (45)
Itepekimab Bronchiectasis	Sanofi	P2	CC (44)
Gdc-6988 Bronchiectasis	Genentech, Inc.	P1	CC (41)
rss0343 tablets Bronchiectasis	Reistone Biopharma Company Limited	P1	CC (41)
XENON Bronchiectasis	University of Kansas Medical Center	Early P1	C (39)
Albuterol Bronchiectasis	Rambam Health Care Campus	N/A	D (30)
Xh-S004 Bronchiectasis	S-INFINITY Pharmaceuticals Co., Ltd	P2	NR ()